Alkermes Plc Revenue per Employee (ALKS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alkermes Plc   (NASDAQ: ALKS)
 

Alkermes Plc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 21.8% in the third quarter 2026, year on year to cumulative value of $1,754 million, Alkermes Plc 's revenue per employee grew on a trailing twelve months basis to $ 855,414. The productivity of Alkermes Plc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 111 other companies have achieved higher revenue per employee. While Alkermes Plc 's total ranking has deteriorated compared to the previous quarter from 459 to 1105. Alkermes Plc has 2,050 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALKS Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 21.8 % 26.97 % 28.19 % -10.57 % 4.24 %
Sales per Employee (TTM) $ 855,414 813,489 762,098 719,951 742,116
ALKS's Total Ranking # 1105 # 459 # 857 # 192 #
Seq. Revenue Change -3.2 % 26.24 % 2.18 % -2.45 % 0.9 %

ALKS Company Profile >> Back to ALKS Efficiency Comparisons >> Compare ALKS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 77
Healthcare Sector # 112
Overall Market # 1105

Revenue per Employee Statistics
High Average Low
$ 842,040 $ 528,711 $ 281,836
(Mar 31 2024)   (Sep 30 2013)



Financial Statements
Alkermes Plc 's Revenue MRQ $ 480 Millions Visit ALKS's Income Statement
Alkermes Plc 's Revenues TTM $ 1,754 Millions Visit ALKS's aggregate revenue growth
What are ALKS's Sales? Visit ALKS's Sales by Segment




Other Ratios
Alkermes Plc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ALKS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ALKS's Competitors
Revenue per Employee for ALKS's Suppliers
Revenue per Employee for ALKS's Customers

You may also want to know
ALKS's Sales Growth Rates ALKS's Pe Price to earnings ratio ALKS's Receivables Turnover Ratio ALKS's Stock Quote
ALKS's Net Income Growth Rates ALKS's Ps Price to Sales ratio ALKS's Sales per Employee ALKS's Asset Turnover Ratio
ALKS's Net Margin ALKS's Pb Price to Book ratio ALKS's Financial Strength Ratios ALKS's Dividend Payout Ratio
Date modified: 2026-11-06T12:59:29+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Arvinas Inc   1,119,105.69 $ 275.300  Million 246 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Ani Pharmaceuticals Inc  1,073,549.48 $ 1,041.343  Million 970 
Verastem Inc   983,294.12 $ 100.296  Million 102 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Alkermes Plc   855,414.15 $ 1,753.599  Million 2,050 
Pfizer Inc  848,333.33 $ 63,625.000  Million 75,000 
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.